Dry Powder Drug Delivery System And Methods

Abstract

A pulmonary drug delivery system is disclosed, including a breath-powered, dry powder inhaler, with or without a cartridge for delivering a dry powder formulation. The inhaler and cartridge can be provided with a drug delivery formulation comprising, for example, a diketopiperazine and an active ingredient, including, small organic molecules, peptides and proteins, including, hormones such as insulin and glucagon-like peptide 1 for the treatment of disease and disorders, for example, diseases and disorders, including endocrine disease such as diabetes and/or obesity.


Claims
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Oct 31, 2017
  • Application: Jul 12, 2013
    US US 201313941365 A
  • Priority: Jul 12, 2013
    US US 201313941365 A
  • Priority: Jul 12, 2012
    US US 201261671041 P

Download Citation


Sign in to the Lens

Feedback